1. Home
  2. ZVRA vs BOC Comparison

ZVRA vs BOC Comparison

Compare ZVRA & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • BOC
  • Stock Information
  • Founded
  • ZVRA 2006
  • BOC 2009
  • Country
  • ZVRA United States
  • BOC United States
  • Employees
  • ZVRA N/A
  • BOC N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • BOC
  • Sector
  • ZVRA Health Care
  • BOC
  • Exchange
  • ZVRA Nasdaq
  • BOC Nasdaq
  • Market Cap
  • ZVRA 473.6M
  • BOC 478.8M
  • IPO Year
  • ZVRA 2015
  • BOC 2017
  • Fundamental
  • Price
  • ZVRA $9.09
  • BOC $14.74
  • Analyst Decision
  • ZVRA Strong Buy
  • BOC Buy
  • Analyst Count
  • ZVRA 7
  • BOC 3
  • Target Price
  • ZVRA $21.20
  • BOC $20.00
  • AVG Volume (30 Days)
  • ZVRA 677.5K
  • BOC 111.7K
  • Earning Date
  • ZVRA 11-12-2024
  • BOC 11-12-2024
  • Dividend Yield
  • ZVRA N/A
  • BOC N/A
  • EPS Growth
  • ZVRA N/A
  • BOC N/A
  • EPS
  • ZVRA N/A
  • BOC N/A
  • Revenue
  • ZVRA $24,489,000.00
  • BOC $105,014,906.00
  • Revenue This Year
  • ZVRA N/A
  • BOC $12.38
  • Revenue Next Year
  • ZVRA $318.48
  • BOC $5.98
  • P/E Ratio
  • ZVRA N/A
  • BOC N/A
  • Revenue Growth
  • ZVRA 47.85
  • BOC 11.51
  • 52 Week Low
  • ZVRA $4.20
  • BOC $12.41
  • 52 Week High
  • ZVRA $9.30
  • BOC $16.99
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 59.84
  • BOC 45.61
  • Support Level
  • ZVRA $8.32
  • BOC $14.38
  • Resistance Level
  • ZVRA $9.27
  • BOC $16.18
  • Average True Range (ATR)
  • ZVRA 0.53
  • BOC 0.46
  • MACD
  • ZVRA 0.00
  • BOC -0.12
  • Stochastic Oscillator
  • ZVRA 81.82
  • BOC 23.96

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a us-based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. They generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: